An avalanche of lawsuits filed against Bayer in Missouri is pitting the chemical maker against trial attorneys and cancer patients.
Simply sign up to the Aerospace & Defence myFT Digest -- delivered directly to your inbox. Artificial intelligence start-up Shield AI will nearly double its valuation to $5bn in a new fundraising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results